Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 235 across all filing types
Latest filing 2025-03-10 Capital/Financing Update
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Updates
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the allotment of equity shares under the Employees Stock Option Plan (ESOP) 2008. It references compliance with SEBI regulations, specifically Regulation 30 of SEBI (LODR) Regulations, 2015, and provides detailed disclosures about the allotment of shares, exercise price, number of shares issued, and other regulatory details. The document is not a financial report, earnings release, or management discussion but rather an update on a capital event related to share allotment under an employee stock option scheme. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share allotments under ESOPs. The document length (8028 characters) and content confirm it is a substantive announcement, not a brief notice or report publication announcement.
2025-03-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 07 March 2025, addressed to stock exchanges, informing about the schedule of a meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is brief (2000 characters) and serves as an intimation or announcement rather than a detailed report or transcript. It does not contain financial data, management discussion, or detailed presentation content. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-03-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is dated March 6, 2025, and references compliance with SEBI regulations. The content is an announcement of a meeting schedule rather than a financial report, earnings release, or presentation. The document length is only 2158 characters, which is quite short and does not contain any financial data or detailed analysis. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for miscellaneous filings that do not fit other specific categories.
2025-03-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 06 March 2025, informing stock exchanges about a scheduled meeting with an analyst/investor on March 11, 2025. It explicitly states that no new presentation will be made and no unpublished price sensitive information will be discussed. The document is an intimation or announcement of an upcoming investor meeting rather than a detailed report or transcript. It does not contain financial data, management discussion, or regulatory filings beyond the meeting notice. The length is only 2155 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-03-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 06 March 2025, informing stock exchanges about a scheduled meeting with an analyst/investor on March 11, 2025. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of a meeting schedule rather than a detailed report or transcript. It does not contain financial data, management discussion, or any detailed presentation materials. Given the short length (2174 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about an investor meeting schedule without substantive financial or strategic content.
2025-03-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 06 March 2025, informing stock exchanges about a scheduled meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of an upcoming investor meeting rather than a detailed investor presentation or financial report. The length is only 2168 characters, which is quite short and does not contain financial data or analysis. Therefore, it is not an Investor Presentation (IP) or any financial report. It fits best under Regulatory Filings (RNS) as a general regulatory announcement about investor meetings, which do not fit other specific categories.
2025-03-06 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.